Agreed, but as I recall, Guardant360 CDx detects actionable biomarkers in known cancers. The proposed Galleri test is a broad screening tool for the general population for over 50 cancers. The future indeed appears brighter. Thanks for reading the piece and reminding us how we use blood in other ways to improve cancer management.

Warm regards,

Michael